98 related articles for article (PubMed ID: 10188794)
1. Mutations of aspartate 103 in the Hm2 receptor and alterations in receptor binding properties of muscarinic agonists.
Schwarz RD; Spencer CJ; Jaen JC; Mirzadegan T; Moreland D; Tecle H; Thomas AJ
Life Sci; 1995; 56(11-12):923-9. PubMed ID: 10188794
[TBL] [Abstract][Full Text] [Related]
2. Interactions of agonists with M2 and M4 muscarinic receptor subtypes mediating cyclic AMP inhibition.
McKinney M; Miller JH; Gibson VA; Nickelson L; Aksoy S
Mol Pharmacol; 1991 Dec; 40(6):1014-22. PubMed ID: 1722002
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological basis for functional selectivity of partial muscarinic receptor agonists.
Heldman E; Barg J; Fisher A; Levy R; Pittel Z; Zimlichman R; Kushnir M; Vogel Z
Eur J Pharmacol; 1996 Feb; 297(3):283-91. PubMed ID: 8666061
[TBL] [Abstract][Full Text] [Related]
4. Transducer abstraction: a novel approach to the detection of partial agonist efficacy in radioligand binding studies.
Christopoulos A; Grant MK; El-Fakahany EE
J Pharmacol Toxicol Methods; 2000; 43(1):55-67. PubMed ID: 11091130
[TBL] [Abstract][Full Text] [Related]
5. Double mutant cycle analysis of aspartate 69, 97, and 103 to asparagine mutants in the m2 muscarinic acetylcholine receptor.
Vogel WK; Peterson GL; Broderick DJ; Mosser VA; Schimerlik MI
Arch Biochem Biophys; 1999 Jan; 361(2):283-94. PubMed ID: 9882458
[TBL] [Abstract][Full Text] [Related]
6. Site-directed mutagenesis of the putative human muscarinic M2 receptor binding site.
Heitz F; Holzwarth JA; Gies JP; Pruss RM; Trumpp-Kallmeyer S; Hibert MF; Guenet C
Eur J Pharmacol; 1999 Sep; 380(2-3):183-95. PubMed ID: 10513578
[TBL] [Abstract][Full Text] [Related]
7. Lack of effect of McN-A-343 on membrane current and contraction in guinea pig ventricular myocytes.
Shen JB; Jiang B; Pappano AJ
J Pharmacol Exp Ther; 1999 Aug; 290(2):641-8. PubMed ID: 10411573
[TBL] [Abstract][Full Text] [Related]
8. Site-directed mutagenesis on the m2 muscarinic acetylcholine receptor: the significance of Tyr403 in the binding of agonists and functional coupling.
Vogel WK; Sheehan DM; Schimerlik MI
Mol Pharmacol; 1997 Dec; 52(6):1087-94. PubMed ID: 9415719
[TBL] [Abstract][Full Text] [Related]
9. Mutagenesis of nucleophilic residues near the orthosteric binding pocket of M1 and M2 muscarinic receptors: effect on the binding of nitrogen mustard analogs of acetylcholine and McN-A-343.
Suga H; Sawyer GW; Ehlert FJ
Mol Pharmacol; 2010 Oct; 78(4):745-55. PubMed ID: 20643905
[TBL] [Abstract][Full Text] [Related]
10. Contrasting effects of carbachol, McN-A-343 and AHR-602 on Ca(2+)-mobilization and Ca(2+)-influx pathways in taenia caeci.
Hishinuma S; Hongo I; Matsumoto Y; Narita F; Kurokawa M
Br J Pharmacol; 1997 Nov; 122(6):985-92. PubMed ID: 9401759
[TBL] [Abstract][Full Text] [Related]
11. Receptor signaling mechanisms underlying muscarinic agonist-evoked contraction in guinea-pig ileal longitudinal smooth muscle.
Unno T; Kwon SC; Okamoto H; Irie Y; Kato Y; Matsuyama H; Komori S
Br J Pharmacol; 2003 May; 139(2):337-50. PubMed ID: 12770939
[TBL] [Abstract][Full Text] [Related]
12. Pharmacologic comparison of selected agonists for the M1 muscarinic receptor in transfected murine fibroblast cells (B82).
Mei L; Lai J; Yamamura HI; Roeske WR
J Pharmacol Exp Ther; 1991 Feb; 256(2):689-94. PubMed ID: 1704434
[TBL] [Abstract][Full Text] [Related]
13. Sialic acid residues as catalysts for M2-muscarinic agonist-receptor interactions.
Haddad EB; Landry Y; Gies JP
Mol Pharmacol; 1990 May; 37(5):682-8. PubMed ID: 1692606
[TBL] [Abstract][Full Text] [Related]
14. Autoradiographic analyses of agonist binding to muscarinic receptor subtypes.
Messer WS; Ellerbrock B; Price M; Hoss W
Biochem Pharmacol; 1989 Mar; 38(5):837-50. PubMed ID: 2564779
[TBL] [Abstract][Full Text] [Related]
15. M1 muscarinic receptor stimulation decreases aspartate release in the rat neostriatum.
Expósito I; Sanz B; Mora F
Neurochem Res; 1997 Dec; 22(12):1485-90. PubMed ID: 9357014
[TBL] [Abstract][Full Text] [Related]
16. Positive cooperativity of acetylcholine and other agonists with allosteric ligands on muscarinic acetylcholine receptors.
Jakubík J; Bacáková L; El-Fakahany EE; Tucek S
Mol Pharmacol; 1997 Jul; 52(1):172-9. PubMed ID: 9224827
[TBL] [Abstract][Full Text] [Related]
17. Muscarinic receptor heterogeneity in rat central nervous system. II. Brain receptors labeled by [3H]oxotremorine-M correspond to heterogeneous M2 receptors with very high affinity for agonists.
Gillard M; Waelbroeck M; Christophe J
Mol Pharmacol; 1987 Jul; 32(1):100-8. PubMed ID: 3600611
[TBL] [Abstract][Full Text] [Related]
18. Characterization of muscarinic receptors mediating relaxation and contraction in the rat iris dilator muscle.
Masuda Y; Yamahara NS; Tanaka M; Ryang S; Kawai T; Imaizumi Y; Watanabe M
Br J Pharmacol; 1995 Feb; 114(4):769-76. PubMed ID: 7539696
[TBL] [Abstract][Full Text] [Related]
19. Different effects of muscarinic agonists in rat superior cervical ganglion and hippocampal slices.
Boddeke HW
Eur J Pharmacol; 1991 Aug; 201(2-3):191-7. PubMed ID: 1724649
[TBL] [Abstract][Full Text] [Related]
20. The role of charge interactions in muscarinic agonist binding, and receptor-response coupling.
Hulme EC; Curtis CA; Page KM; Jones PG
Life Sci; 1995; 56(11-12):891-8. PubMed ID: 10188790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
